February
Market Access NHS England: In conversation with Neil Grubert
What’s changing in NHS England’s market access landscape and what Life Sciences teams need to know now
NHS England is under pressure to reform, rebalance and deliver more value. Join market access expert Neil Grubert for a strategic look at how those shifts are playing out across access policy, payer priorities and evidence expectations in 2026.
Nordic Market Access Made Simple
Clear insight into payer pathways and decision-making across Denmark, Finland, Norway and Sweden
Join Nordic market access expert Katja Lundell for a practical guide to navigating payer pathways across the region. Gain clarity on how decisions are made, who holds influence and what strategies can speed patient access to innovative medicines.